Innovative Diagnostic Technology iSono Health has developed a cutting-edge portable and automated 3D breast ultrasound system powered by AI, offering a fast two-minute scan without radiation. This positions the company well to target clinics and healthcare providers seeking advanced, accessible breast cancer screening solutions.

Expanding Global Reach With a strategic partnership with Abdul Latif Jameel Health to distribute the ATUSA scanner across 31 countries in the Middle East, North Africa, Africa, South Asia, and Southeast Asia, there is a significant opportunity to scale sales in emerging markets where access to early detection tools is critical.

Strong Industry Recognition Receiving the Frost & Sullivan U.S. New Product Innovation Award in 2023 and ongoing NIH-funded clinical validations enhance the company's credibility, making it easier to approach hospitals, radiology centers, and government health agencies for purchase and integration.

Funding and Growth Potential With recent funding rounds of around USD 5 million, iSono Health is positioned for continued product development and market expansion. This financial backing can be leveraged in sales pitches to showcase growth potential and technological leadership.

Market Opportunity The large and growing breast cancer screening market, combined with increasing global emphasis on early detection, presents substantial sales opportunities within healthcare institutions, mobile clinics, and preventive health programs eager for innovative, easy-to-use diagnostic tools.